• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Pfizer

Anonymous board for Pfizer.
Replies
2
Views
635
Anonymous
Replies
6
Views
2K
Anonymous
Replies
20
Views
2K
Anonymous
Replies
2
Views
711
Anonymous
Replies
7
Views
1K
Anonymous
Replies
29
Views
4K
Anonymous
Replies
0
Views
575
Anonymous
Replies
8
Views
1K
Anonymous
Replies
3
Views
1K
Anonymous
Replies
15
Views
3K
Anonymous
Replies
7
Views
2K
Anonymous
Replies
6
Views
2K
Anonymous
Replies
2
Views
1K
Anonymous
Replies
5
Views
1K
Anonymous